TrademarkOpen
Search / United States / 98132272

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

ELEVAR

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Pharmaceutical preparations, namely, experimental and novel cancer therapeutics

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 17 Aug 2023
    Application filed
    Nwap
  2. 8 Feb 2024
    Assigned to an examining attorney
    Dock
  3. 9 Feb 2024
    Approved for publication
    Cnsa
  4. 19 Mar 2024
    Published for opposition
    Pubo
  5. 14 May 2024
    Notice of allowance issued — statement of use required
    Noam
  6. 15 Oct 2024
    Statement-of-use extension 1 granted
    Ex1g
  7. 13 May 2025
    Statement-of-use extension 2 granted
    Ex2g
  8. 31 Oct 2025
    Statement-of-use extension 3 granted
    Ex3g
All 25 events
2026-02-24Exra
2026-02-23Eext
2026-02-23Ext4
2026-02-23Ex4g
2025-10-31Eext
2025-10-31Ext3
2025-10-31Ex3g
2025-10-31Exra
2025-05-13Ex2g
2025-05-13Exra
2025-05-12Eext
2025-05-12Ext2
2024-10-21Exra
2024-10-15Eext
2024-10-15Ext1
2024-10-15Ex1g
2024-05-14Noam
2024-03-19Pubo
2024-03-19Npub
2024-02-28Nonp
2024-02-28Npub
2024-02-09Cnsa
2024-02-08Dock
2023-09-13Nwos
2023-08-17Nwap

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations, namely, experimental and novel cancer therapeutics

Source & freshness

Source: the official United States trademark register. This record was last updated on 25 Feb 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.